About the Authors
- Shalini Pullarkat
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Graeme Black
-
Roles Resources
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Marie Bleakley
-
Roles Resources, Writing – review & editing
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Pediatrics, University of Washington, Seattle, Washington, United States of America, Program in Immunology, University of Washington, Seattle, Washington, United States of America
- Denise Buenrostro
-
Roles Resources
Affiliations Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Program in Immunology, University of Washington, Seattle, Washington, United States of America
- Aude G. Chapuis
-
Roles Resources
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Program in Immunology, University of Washington, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America
- Alexandre V. Hirayama
-
Roles Conceptualization, Resources
Affiliations Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America
- Carla A. Jaeger-Ruckstuhl
-
Roles Resources, Writing – review & editing
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Erik L. Kimble
-
Roles Conceptualization, Methodology, Resources, Writing – review & editing
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America
- Bo M. Lee
-
Roles Resources
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- David G. Maloney
-
Roles Resources
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America
- Jerald Radich
-
Roles Resources, Supervision, Writing – review & editing
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Brandon W. Seaton
-
Roles Resources
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Jennifer M. Specht
-
Roles Funding acquisition, Resources, Writing – review & editing
Affiliations Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America
- Cameron J. Turtle
-
Roles Conceptualization, Methodology
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, United States of America, Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Center, Seattle, WA, United States of America
- David W. Woolston
-
Roles Conceptualization, Methodology, Visualization, Writing – review & editing
Affiliation Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America
- Jocelyn H. Wright
-
Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Program in Immunology, University of Washington, Seattle, Washington, United States of America
- Cecilia C. S. Yeung
-
Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing
* E-mail: cyeung5@uw.edu
Affiliations Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America, Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America
Competing Interests
All authors have read and understand PLOS ONE’s policies. The below commercial interests did not fund and have no association with the work performed in this study; therefore, this does not alter our adherence to PLOS ONE’s policies on sharing data and materials. The authors of this manuscript have the following competing interests: A.G.C. received research funding from Juno Therapeutics, a Bristol Myers Squibb Company. E.K. received research funding from Juno Therapeutics, a Bristol Myers Squibb Company. A.V.H. has received research funding from Juno Therapeutics, a Bristol Myers Squibb Company, and Nektar Therapeutics; has received honoraria from Bristol Myers Squibb. C.J.T. has received research funding from Juno Therapeutics/BMS, Nektar Therapeutics. C.J.T. is on the scientific advisory board for Caribou Biosciences, T-CURX, Myeloid Therapeutics, ArsenalBio, Cargo Therapeutics, Celgene/BMS Cell Therapy. C.J.T. is a DSMB member for Kyverna. C.J.T. ad hoc advisory boards/consulting (last 12 months) include: Nektar Therapeutics, Century Therapeutics, Legend Biotech, Allogene, Sobi, Syncopation Life Sciences, Prescient Therapeutics, Orna Therapeutics, IGM Biosciences, Abbvie. C.J.T. stock options: Eureka Therapeutics, Caribou Biosciences, Myeloid Therapeutics, ArsenalBio, Cargo Therapeutics. C.J.T. has the right to receive payment from Fred Hutch as an inventor on patents related to CAR T-cell therapy C.Y. has received research funding from Minerva, Lonza. C.Y. consults for TwinStrand Biosciences.